Kandaswamy Vijayan

USPTO Granted Patents = 42 (Patent Applications = 15)

CIPO Patents = 13 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 20)

Average Co-Inventor Count = 3.8

ph-index = 11

Forward Citations = 511(Granted Patents)

Company Filing History:

Pacific Biosciences of California, Inc.

patents

5. 1 out of 32

Bionano Genomics, Inc.

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid Sequencing

Oligonucleotide Encoded Libraries

Microarray Fabrication

Kinetic Exclusion Amplification

Sequencing By Binding

Target Nucleic Acid Quantification

Polymerase Engineering

Combinatorial Libraries

Assay Devices

Ternary Complex Detection

Single-Molecule Genome Analysis

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344890 - Process for cognate nucleotide detection in a nucleic acid sequencing workflow (2025-07-01),

2. 12180545 - Methods and apparatus that increase sequencing-by-binding efficiency (2024-12-31),

3. 12030057 - Oligonucleotide encoded chemical libraries (2024-07-09),

4. 11998919 - Assay devices for combinatorial libraries (2024-06-04),

5. 11976323 - Method of nucleic acid sequence determination (2024-05-07),

6. 11834704 - Microarray fabrication system and method (2023-12-05),

7. 11577249 - Oligonucleotide encoded chemical libraries (2023-02-14),

8. 11499185 - Nucleic acid sequencing methods and systems (2022-11-15),

9. 11447823 - Methods and apparatus that increase sequencing-by-binding efficiency (2022-09-20),

10. 11326206 - Methods of quantifying target nucleic acids and identifying sequence variants (2022-05-10),

11. 11305288 - Assay devices for combinatorial libraries (2022-04-19),

12. 11254976 - Kinetic exclusion amplification of nucleic acid libraries (2022-02-22),

13. 11248254 - Method and system employing distinguishable polymerases for detecting ternary complexes and identifying cognate nucleotides (2022-02-15),

14. 11203779 - Sequencing method for rapid identification and processing of cognate nucleotide pairs (2021-12-21),

15. 11203778 - Sequencing method employing ternary complex destabilization to identify cognate nucleotides (2021-12-21),

Title: Innovating Genomic Sequencing: The Impact of Kandaswamy Vijayan

Introduction: Kandaswamy Vijayan is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of genomic sequencing. With a remarkable portfolio consisting of 41 patents, Vijayan's innovative work is shaping the future of molecular biology and diagnostics.

Latest Patents: Among his notable patents, Vijayan has developed methods and apparatus that increase sequencing-by-binding efficiency. This invention involves a sophisticated method of determining nucleic acid sequences through the formation of ternary complexes using specific mixtures that include polymerase and nucleotide cognates. The process monitors signal states to accurately ascertain base calls, improving the reliability of sequence interpretations. Furthermore, Vijayan's invention of oligonucleotide-encoded chemical libraries focuses on a bead design that incorporates a covalently attached chemical compound and a DNA barcode. This innovative bead allows for the identification of chemical monomers and enables methods for sequencing and assessing the biological activity of the compounds.

Career Highlights: Kandaswamy Vijayan's career includes significant tenure at notable companies such as Omniome, Inc. and Illumina Corporation, where he contributed to advancements in genetic sequencing technologies. His work at these firms has empowered scientists and researchers to improve genomic analysis methods, thus enhancing the understanding of genetic information.

Collaborations: Throughout his career, Vijayan has collaborated with distinguished professionals including M Shane Bowen and Kevin L Gunderson. These partnerships have fostered a dynamic environment for innovation and facilitated the advancement of important research in the field of genomics.

Conclusion: Kandaswamy Vijayan exemplifies the spirit of innovation in biotechnology, with his patents paving the way for more efficient sequencing methods. His work not only reflects his expertise but also showcases the potential of collaboration in driving advancements within the scientific community. As the landscape of genomic technologies continues to evolve, the contributions of inventors like Vijayan will remain pivotal in shaping the future of biology and medicine.

This text is generated by artificial intelligence and may not be accurate.